EMD-50833

Single-particle
3.3 Å
EMD-50833
3D View Gallery
Deposition: 30/06/2024
Map released: 26/02/2025
Last modified: 05/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-50833

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9fwf summary report (pdf.gz) Map-9fwf FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

N-VelcroVax HBcAg with SUMO-Affimer inserted at N-terminus (T=4 VLP)

EMD-50833

Single-particle
3.3 Å
EMD-50833
3D View Gallery
Deposition: 30/06/2024
Map released: 26/02/2025
Last modified: 05/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: synthetic construct
Sample: T=4 virus-like particle for N-VelcroVax HBcAg
Fitted models: 9fwf

Deposition Authors: Fatema K, Snowden JS, Watson A, Sherry L , Ranson NA, Stonehouse NJ, Rowlands DJ
A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture.
Fatema K, Snowden JS, Watson A, Sherry L , Ranson NA, Stonehouse NJ, Rowlands DJ
(2025) Int J Biol Macromol , 305 , 141152 - 141152
PUBMED: 39961558
DOI: doi:10.1016/j.ijbiomac.2025.141152
ISSN: 0141-8130
ASTM: IJBMDR
Grant Support: